Plain-English translation of NCT04544969 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether a special blood test can help doctors predict how well chemotherapy will work for people with advanced nasopharyngeal cancer (a type of throat cancer that has spread to other parts of the body). The test detects cancer cells circulating in your blood and tracks how they change during treatment. The goal is to give doctors better information upfront about which patients are likely to benefit from chemotherapy.
Currently, doctors prescribe chemotherapy based on general guidelines, but every patient responds differently. This study aims to fill that gap by using blood tests to personalize treatment predictions, so doctors can better understand which patients will benefit most from this medication before starting treatment.
You likely qualify if…
You likely don't qualify if…
You will receive standard chemotherapy treatment for your cancer as planned with your doctor. Throughout your treatment, researchers will draw blood samples at specific times to test for circulating cancer cells and see how they respond to the chemotherapy. These blood draws are in addition to any routine blood tests your doctor already orders. The study team will track how your cancer responds to treatment and compare those results with the blood test findings.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Sun Yat-sen University
Enrollment target
~50 participants
Started
April 2020
Primary completion
December 2026
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jingjing Miao, M.D
Sun Yat-sen University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.